某些神经系统疾病中的慢性疲劳综合征羟化酶辅助因子水平。
CFS hydroxylase cofactor levels in some neurological diseases.
作者信息
Williams A C, Levine R A, Chase T N, Lovenberg W, Calne D B
出版信息
J Neurol Neurosurg Psychiatry. 1980 Aug;43(8):735-8. doi: 10.1136/jnnp.43.8.735.
Abstract
The cerebrospinal fluid concentration of hydroxylase cofactor has been measured in patients with Parkinson's disease, the Shy-Drager and Steele-Richardson syndromes, adult onset focal dystonia, essential tremor, Huntington's disease and presenile dementia. The results were compared with age matched controls and low values were demonstrated for all disease groups studied except for focal dystonia.
摘要
已对帕金森病、夏伊-德雷格综合征和斯蒂尔-理查森综合征、成人起病的局限性肌张力障碍、特发性震颤、亨廷顿病和早老性痴呆患者的脑脊液羟化酶辅因子浓度进行了测量。将结果与年龄匹配的对照组进行比较，结果显示，除局限性肌张力障碍外，所有研究的疾病组该浓度值均较低。
相似文献
1
CFS hydroxylase cofactor levels in some neurological diseases.某些神经系统疾病中的慢性疲劳综合征羟化酶辅助因子水平。
J Neurol Neurosurg Psychiatry. 1980 Aug;43(8):735-8. doi: 10.1136/jnnp.43.8.735.
2
Serum dopamine-beta-hydroxylase activity in patients with Huntington's chorea and Parkinson's disease.亨廷顿舞蹈症和帕金森病患者的血清多巴胺-β-羟化酶活性
Lancet. 1972 Jan 15;1(7742):153-4. doi: 10.1016/s0140-6736(72)90725-8.
3
4
[Neurologic indications for bromocriptine (in addition to Parkinson's disease)].[溴隐亭的神经学适应症（除帕金森病外）]
LARC Med. 1984 Feb;4(2):107-11.
5
Tryptophan hydroxylase activity in the brains of controls and parkinsonian patients.对照组和帕金森病患者大脑中的色氨酸羟化酶活性。
J Neural Transm. 1985;62(1-2):107-15. doi: 10.1007/BF01260420.
6
Cerebrospinal fluid "specific" proteins in various degenerative neurological diseases.各种退行性神经疾病中的脑脊液“特异性”蛋白质。
Acta Neurol Scand. 1982 Aug;66(2):199-208. doi: 10.1111/j.1600-0404.1982.tb04517.x.
7
[Parkinson "plus"].[帕金森叠加综合征]
Rev Prat. 1997 May 15;47(10):1077-82.
8
[An autopsied case of Parkinson's disease manifesting Shy-Drager syndrome].[一例表现为Shy-Drager综合征的帕金森病尸检病例]
Rinsho Shinkeigaku. 1992 Nov;32(11):1238-44.
9
Sleep and degenerative neurologic disorders.睡眠与退行性神经疾病。
Neurol Clin. 1996 Nov;14(4):807-26. doi: 10.1016/s0733-8619(05)70286-3.
10
Chapter 33: the history of movement disorders.第33章：运动障碍病史。
Handb Clin Neurol. 2010;95:501-46. doi: 10.1016/S0072-9752(08)02133-7.
引用本文的文献
1
Tetrahydrobiopterin Improves Recognition Memory in the Triple-Transgenic Mouse Model of Alzheimer's Disease, Without Altering Amyloid-β and Tau Pathologies.四氢生物蝶呤改善阿尔茨海默病三转基因小鼠模型的识别记忆，而不改变淀粉样蛋白-β 和 tau 病理学。
J Alzheimers Dis. 2021;79(2):709-727. doi: 10.3233/JAD-200637.
2
Metabolomic Responses to Manganese Dose in SH-SY5Y Human Neuroblastoma Cells.锰剂量对 SH-SY5Y 人神经母细胞瘤细胞的代谢组学反应。
Toxicol Sci. 2019 May 1;169(1):84-94. doi: 10.1093/toxsci/kfz028.
3
Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease.帕金森病患者的脑脊液生化研究：寻找这种疾病潜在生物标志物的方法。
Front Cell Neurosci. 2014 Nov 11;8:369. doi: 10.3389/fncel.2014.00369. eCollection 2014.
4
Tetrahydrobiopterin availability in Parkinson's and Alzheimer's disease; potential pathogenic mechanisms.帕金森病和阿尔茨海默病中四氢生物蝶呤的可利用性；潜在的致病机制。
Neurochem Res. 2007 Apr-May;32(4-5):751-6. doi: 10.1007/s11064-006-9201-0. Epub 2006 Dec 27.
5
Immunocytochemical localization of GTP cyclohydrolase I in the brain, adrenal gland, and liver of mice.小鼠脑、肾上腺和肝脏中GTP环化水解酶I的免疫细胞化学定位
J Neural Transm Gen Sect. 1995;102(3):175-188. doi: 10.1007/BF01281153.
6
Isolation of a full-length cDNA clone for human GTP cyclohydrolase I type 1 from pheochromocytoma.从嗜铬细胞瘤中分离人1型GTP环化水解酶的全长cDNA克隆。
J Neural Transm Gen Sect. 1995;101(1-3):237-42. doi: 10.1007/BF01271561.
7
Meningitis and disseminated cutaneous zoster complicating herpes zoster infection.脑膜炎和播散性皮肤带状疱疹并发带状疱疹感染。
J Neurol Neurosurg Psychiatry. 1983 Jun;46(6):582-3. doi: 10.1136/jnnp.46.6.582-a.
8
Tetrahydrobiopterin metabolism in senile dementia of Alzheimer type.阿尔茨海默病型老年痴呆中的四氢生物蝶呤代谢
J Neurol Neurosurg Psychiatry. 1983 Jun;46(6):582. doi: 10.1136/jnnp.46.6.582.
9
Biosynthesis of tetrahydrobiopterin by de novo and salvage pathways in adrenal medulla extracts, mammalian cell cultures, and rat brain in vivo.肾上腺髓质提取物、哺乳动物细胞培养物及大鼠脑内通过从头合成途径和补救途径进行四氢生物蝶呤的生物合成。
Proc Natl Acad Sci U S A. 1983 Mar;80(6):1546-50. doi: 10.1073/pnas.80.6.1546.
10
Tetrahydrobiopterin metabolism in senile dementia of Alzheimer type.阿尔茨海默病型老年痴呆症中的四氢生物蝶呤代谢
J Neurol Neurosurg Psychiatry. 1983 May;46(5):410-3. doi: 10.1136/jnnp.46.5.410.
本文引用的文献
1
Action tremor and the cogwheel phenomenon in Parkinson's disease.帕金森病中的动作性震颤和齿轮现象。
Brain. 1963 Mar;86:95-110. doi: 10.1093/brain/86.1.95.
2
A survey of drug-induced extrapyramidal reactions.药物引起的锥体外系反应调查。
JAMA. 1961 Mar 25;175:1054-60. doi: 10.1001/jama.1961.03040120016004.
3
A simple radioisotope assay for phenylalanine hydroxylase cofactor.一种用于苯丙氨酸羟化酶辅因子的简单放射性同位素测定法。
Anal Biochem. 1967 Nov;21(2):273-8. doi: 10.1016/0003-2697(67)90189-3.
4
Biochemical and pharmacologic studies of dystonia.肌张力障碍的生化与药理学研究。
Neurology. 1970 Nov;20(11):122-30. doi: 10.1212/wnl.20.11_part_2.122.
5
Preliminary remarks on the L-dopa therapy of dystonia.关于左旋多巴治疗肌张力障碍的初步论述
Neurology. 1970 Nov;20(11):114-21. doi: 10.1212/wnl.20.11_part_2.114.
6
In vivo enhancement of tyrosine hydroxylation in rat striatum by tetrahydrobiopterin.四氢生物蝶呤对大鼠纹状体酪氨酸羟化作用的体内增强效应。
Nature. 1974 May 31;249(456):476-8. doi: 10.1038/249476a0.
7
Brain aluminum distribution in Alzheimer's disease and experimental neurofibrillary degeneration.阿尔茨海默病及实验性神经原纤维变性中的脑铝分布
Science. 1973 May 4;180(4085):511-3. doi: 10.1126/science.180.4085.511.
8
Effect of the beta adrenergic blocking agent propranolol on essential tremor.β-肾上腺素能阻滞剂普萘洛尔对特发性震颤的作用。
J Neurol Neurosurg Psychiatry. 1973 Aug;36(4):618-24. doi: 10.1136/jnnp.36.4.618.
9
Huntington's chorea. Post-mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia.亨廷顿舞蹈症。基底神经节中谷氨酸脱羧酶、胆碱乙酰转移酶和多巴胺的尸检测量
Brain. 1974 Sep;97(3):457-72. doi: 10.1093/brain/97.1.457.
10
Phenylketonuria due to a deficiency of dihydropteridine reductase.由于二氢蝶啶还原酶缺乏所致的苯丙酮尿症。
N Engl J Med. 1975 Oct 16;293(16):785-90. doi: 10.1056/NEJM197510162931601.
Zotero 插件